[go: up one dir, main page]

MA42618A - Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés - Google Patents

Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés

Info

Publication number
MA42618A
MA42618A MA042618A MA42618A MA42618A MA 42618 A MA42618 A MA 42618A MA 042618 A MA042618 A MA 042618A MA 42618 A MA42618 A MA 42618A MA 42618 A MA42618 A MA 42618A
Authority
MA
Morocco
Prior art keywords
fatty acids
cétyl
preparation
system used
cetyl
Prior art date
Application number
MA042618A
Other languages
English (en)
Other versions
MA42618B1 (fr
Inventor
Paolo Bondioli
Andrea Lacorte
Germano Tarantino
Original Assignee
Pharmanutra S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmanutra S P A filed Critical Pharmanutra S P A
Publication of MA42618A publication Critical patent/MA42618A/fr
Publication of MA42618B1 publication Critical patent/MA42618B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/003Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/24Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533Monocarboxylic acid esters having only one carbon-to-carbon double bond
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/08Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with fatty acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
MA42618A 2015-08-14 2016-08-09 Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés MA42618B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB2015A003130A ITUB20153130A1 (it) 2015-08-14 2015-08-14 Acidi grassi cetilati, impianto per la loro preparazione e relativo uso
PCT/IB2016/054788 WO2017029580A1 (fr) 2015-08-14 2016-08-09 Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés

Publications (2)

Publication Number Publication Date
MA42618A true MA42618A (fr) 2021-04-07
MA42618B1 MA42618B1 (fr) 2021-10-29

Family

ID=55069943

Family Applications (1)

Application Number Title Priority Date Filing Date
MA42618A MA42618B1 (fr) 2015-08-14 2016-08-09 Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés

Country Status (22)

Country Link
US (2) US10597608B2 (fr)
EP (2) EP3943478A1 (fr)
CN (1) CN108137472B (fr)
CA (1) CA2995314C (fr)
CY (1) CY1124710T1 (fr)
DK (1) DK3334705T3 (fr)
ES (1) ES2897903T3 (fr)
HR (1) HRP20211702T1 (fr)
HU (1) HUE056361T2 (fr)
IL (2) IL257143B (fr)
IT (1) ITUB20153130A1 (fr)
LT (1) LT3334705T (fr)
MA (1) MA42618B1 (fr)
MD (1) MD3334705T2 (fr)
MY (1) MY182324A (fr)
PL (1) PL3334705T3 (fr)
PT (1) PT3334705T (fr)
RS (1) RS62429B1 (fr)
RU (1) RU2756515C2 (fr)
SI (1) SI3334705T1 (fr)
SM (1) SMT202100697T1 (fr)
WO (1) WO2017029580A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
IT201900007326A1 (it) * 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) * 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT201900007329A1 (it) * 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
IT202100030170A1 (it) 2021-11-29 2023-05-29 Pharmanutra S P A Cerotto transdermico, e uso di detto cerotto in un metodo di trattamento di un disturbo, o disordine, o patologia, di un tendine
IT202300004227A1 (it) 2023-03-07 2024-09-07 Pharmanutra S P A Composizioni comprendenti acidi grassi cetilati e vitamina d, e loro usi relativi
CN116693390A (zh) * 2023-06-28 2023-09-05 广东聚石科技研究院有限公司 一种鲸蜡硬脂醇与脂肪酸的组合物及其制备方法与应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049824A (en) * 1976-05-03 1977-09-20 Harry Weldon Diehl Cetyl myristoleate
DE3468433D1 (en) * 1983-05-19 1988-02-11 Asahi Denka Kogyo Kk Reaction method for transesterifying fats and oils
GB2233227A (en) * 1989-06-09 1991-01-09 Paul Eldred Buckenham Zinc compositions for treatment of foot odour
CN1197688A (zh) * 1997-04-29 1998-11-04 德国泰克萨科股份公司 在反应塔中物质的化学反应方法
US5898077A (en) * 1997-10-07 1999-04-27 Matsumoto Yushi-Seiyaku Co., Ltd. Process for preparation of an ester
WO2001085162A1 (fr) * 2000-05-12 2001-11-15 Meracol Corporation Limited Traitement du syndrome ou de la maladie du colon irritable
NZ522434A (en) * 2001-05-11 2005-09-30 Meracol Corp Ltd Treating eczema and/or psoriasis
CA2459087C (fr) * 2001-08-31 2011-04-19 Dianne Cadwallader Synthese de fragments alkyle a chaine longue a liaison ester
DE10251984A1 (de) * 2002-11-08 2004-05-19 Cognis Deutschland Gmbh & Co. Kg Verfahren zur Herstellung eines Esters
TWI324592B (en) * 2002-11-28 2010-05-11 Sulzer Chemtech Ag A method for the esterification of a fatty acid
WO2004084829A2 (fr) * 2003-03-20 2004-10-07 Imagenetix, Inc. Composition d'acide gras esterifie
RU2228745C1 (ru) * 2003-04-16 2004-05-20 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Адаптогенный лекарственный перепарат для перорального применения
US8815282B1 (en) * 2005-07-15 2014-08-26 Edward C. Leonard Commercial method for production of room temperature-liquid cetyl myristoleate
US7276621B2 (en) * 2005-08-12 2007-10-02 Eastman Chemical Company Production of di-(2-ethylhexyl) terephthalate
BRPI0818795A8 (pt) * 2007-10-30 2016-04-26 Bayer Technology Services Gmbh Processo para a esterificação heterogenicamente catalisada de ácidos graxos
US8394759B2 (en) * 2008-11-21 2013-03-12 Cymbiotics, Inc. Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes
US20110039928A1 (en) * 2009-08-13 2011-02-17 Golini Jeffrey M Cetylated fatty acid and alkali buffered creatine anti-inflammatory composition
US20110135627A1 (en) * 2009-10-07 2011-06-09 The Inflasoothe Group, Inc. Pain relief composition, system and method
EP2543364A1 (fr) * 2010-10-14 2013-01-09 Deva Holding Anonim Sirketi Formulations de cetyl myristate et/ou cetyl palmitate
CN103880656A (zh) * 2012-12-24 2014-06-25 青岛帅王油脂化学有限公司 一种脂肪酸酯化的方法

Also Published As

Publication number Publication date
HRP20211702T1 (hr) 2022-02-04
HK1254896A1 (zh) 2019-08-02
IL257143B (en) 2022-08-01
ES2897903T3 (es) 2022-03-03
MY182324A (en) 2021-01-19
RU2756515C2 (ru) 2021-10-01
MD3334705T2 (ro) 2022-01-31
CA2995314A1 (fr) 2017-02-23
US20190016991A1 (en) 2019-01-17
US11186536B2 (en) 2021-11-30
LT3334705T (lt) 2021-12-10
RU2018108294A (ru) 2019-09-16
ITUB20153130A1 (it) 2017-02-14
MA42618B1 (fr) 2021-10-29
CN108137472A (zh) 2018-06-08
IL294422B2 (en) 2024-07-01
US10597608B2 (en) 2020-03-24
IL257143A (en) 2018-03-29
WO2017029580A1 (fr) 2017-02-23
EP3334705B1 (fr) 2021-09-15
RS62429B1 (sr) 2021-11-30
PT3334705T (pt) 2021-11-04
DK3334705T3 (da) 2021-11-01
EP3943478A1 (fr) 2022-01-26
US20200181530A1 (en) 2020-06-11
SI3334705T1 (sl) 2021-12-31
IL294422A (en) 2022-08-01
SMT202100697T1 (it) 2022-01-10
PL3334705T3 (pl) 2022-01-10
RU2018108294A3 (fr) 2020-05-18
IL294422B1 (en) 2024-03-01
HUE056361T2 (hu) 2022-02-28
CY1124710T1 (el) 2022-07-22
EP3334705A1 (fr) 2018-06-20
CN108137472B (zh) 2021-08-03
CA2995314C (fr) 2024-01-09

Similar Documents

Publication Publication Date Title
MA42618A (fr) Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés
EP3448386A4 (fr) Isoquinolin-3-yl carboxamides et préparation et utilisation de ceux-ci
EP3394825A4 (fr) Plateforme et système de médecine personnalisée numérique
EP3448838A4 (fr) Isoquinolin-3-yl carboxamides et préparation et utilisation de ceux-ci
IL261805A (en) Method and apparatus for delivery of therapeutic agents
EP3265113A4 (fr) Anticorps anti-lilrb et leur utilisation pour détecter et traiter un cancer
IL259571A (en) Cannabis oil compositions and methods for preparation thereof
IL289099A (en) Methods for the storage of whole blood, and compositions thereof
EP3364969A4 (fr) Méthodes de préparation de lymphocytes t pour traitement par lymphocytes t
EP3436902A4 (fr) Système d'interface homme-ordinateur
MA50482A (fr) Dérivés cyclisés de sulfamoylarylamide et leur utilisation comme médicaments pour le traitement de l'hépatite b
MA45613A (fr) Composés polycycliques-carbamoylpyridones et leur utilisation pharmaceutique
EP3385262A4 (fr) Inhibiteur de protéine kinase, son procédé de préparation et son utilisation médicale
EP2914256A4 (fr) Acides aminés disubstitués et procédés de préparation et d'utilisation de ceux-ci
IL252418B (en) Envenomation therapies and related pharmaceutical compositions, systems and kits
EP3295988A4 (fr) Microsonde endoscopique oct, système d'imagerie oct, et son procédé d'utilisation
DK3474931T3 (da) Botulinumtoksin-forfyldt sprøjtesystem
EP3381451A4 (fr) Composition pharmaceutique utilisée pour réduire la graisse localisée et utilisation de la composition pharmaceutique
IL257371A (en) Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredient
EP3131465A4 (fr) Système et procédé pour une émission améliorée de la lumière vers et depuis des sujets
EP3435788A4 (fr) Comprimés bicouches de vitamines et leur procédé de préparation
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
EP3145562A4 (fr) Appareil et procédé pour la préparation et l'administration de composants sanguins
EP3395329A4 (fr) Procédé de préparation de corps lipidiques et leur utilisation
EP3344613A4 (fr) Composés hétéroaryle et leur utilisation comme médicaments thérapeutiques